First agent shown to be effective in maniac phase of BPD is
**Core Concept**
Lithium is a mood stabilizer used primarily in the treatment of bipolar disorder (BPD), particularly in managing manic episodes. Its effectiveness in this context is attributed to its ability to modulate neurotransmitter activity, including the regulation of serotonin and dopamine levels.
**Why the Correct Answer is Right**
Lithium's efficacy in treating the manic phase of BPD was first demonstrated in the 1940s and 1950s. It is believed to exert its therapeutic effects by inhibiting the reuptake of serotonin and norepinephrine, thereby increasing their availability in the synaptic cleft. Additionally, lithium has been shown to reduce the activity of the enzyme inositol monophosphate, which is involved in the signaling pathway of phosphatidylinositol 3-kinase (PI3K). This action ultimately leads to a decrease in the activity of various neurotransmitters, including dopamine, which contributes to the development of manic episodes.
**Why Each Wrong Option is Incorrect**
**Option B:** Valproate is also a mood stabilizer used in the treatment of BPD, but it was not the first agent shown to be effective in the maniac phase. Valproate's mechanism of action involves the inhibition of the enzyme sodium-dependent inorganic anion transporter, which regulates the levels of various neurotransmitters.
**Option C:** Lamotrigine is an anticonvulsant medication that has also been found to be effective in treating depressive episodes in patients with BPD. However, it was not the first agent to demonstrate efficacy in the maniac phase.
**Option D:** Carbamazepine is another anticonvulsant medication that has been used in the treatment of BPD, particularly in managing manic episodes. However, it was not the first agent to be shown to be effective in this context.
**Clinical Pearl / High-Yield Fact**
When initiating lithium therapy, it is essential to monitor serum lithium levels closely to avoid toxicity. A serum lithium level of 1.2-1.5 mmol/L is generally considered therapeutic, while levels above 2.0 mmol/L can lead to toxicity.
β Correct Answer: A. Lithium